ABSTRACT: Polycyclic aromatic hydrocarbons (PAHs) are environmental and tobacco carcinogens. Proximate carcinogenic PAH trans-dihydrodiols are activated by human aldo-keto reductases (AKRs) to yield electrophilic and redox-active o-quinones. Interconversion among benzo [a]pyrene (B[a]P)-7,8-dione, a representative PAH o-quinone, and its corresponding catechol generates a futile redox-cycle with the concomitant production of reactive oxygen species (ROS). We investigated whether glucuronidation of B[a]P-7,8-catechol by human UDP glucuronosyltransferases (UGTs) could intercept the catechol in three different human lung cells. RT-PCR showed that UGT1A1, 1A3, and 2B7 were only expressed in human lung adenocarcinoma A549 cells. The corresponding recombinant UGTs were examined for their kinetic constants and product profile using B[a]P-7,8-catechol as a substrate. B[a]P-7,8-dione was reduced to B[a]P-7,8-catechol by dithiothreitol under anaerobic conditions and then further glucuronidated by the UGTs in the presence of uridine-5′-diphosphoglucuronic acid as a glucuronic acid group donor. UGT1A1 catalyzed the glucuronidation of B[a]P-7,8-catechol and generated two isomeric O-monoglucuronsyl-B[a]P-7,8-catechol products that were identified by RP-HPLC and by LC-MS/MS. By contrast, UGT1A3 and 2B7 catalyzed the formation of only one monoglucuronide, which was identical to that formed in A549 cells. The kinetic profiles of three UGTs followed Michaelis−Menten kinetics. On the basis of the expression levels of UGT1A3 and UGT2B7 and the observation that a single monoglucuronide was produced in A549 cells, we suggest that the major UGT isoforms in A549 cells that can intercept B[a]P-7,8-catechol are UGT1A3 and 2B7.
■ INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are characterized by the presence of two or more fused benzene rings arranged in various configurations. 1 PAHs are ubiquitous airborne environmental pollutants that arise from the incomplete combustion of fossil fuels and are also present in automobile exhaust and firstand secondhand cigarette smoke. PAHs are one of the major classes of carcinogens found in tobacco smoke and are suspect lung carcinogens. Benzo[a]pyrene (B[a]P), the most studied PAH, has been recently upgraded to a Group 1 "known human carcinogen" by the International Agency for Research on Cancer. 2, 3 PAHs are not biological reactive, and the biotransformation of PAHs to electrophilic metabolites is required to elicit their tumorigenic effects. 4 There are three major routes for PAH activation which include the formation of radical cations, 5 diol epoxides, 4, 6 and electrophilic and redox-active o-quinones. 7 In the o-quinone pathway, AKRs catalyze the oxidation of proximate PAH carcinogens, trans-dihydrodiols, to yield ketols which spontaneously rearrange to catechols. PAH catechols are not stable and undergo autooxidation to form PAH o-quinones with the concomitant production of reactive oxygen species (ROS) ( Figure 1 ). 8−11 PAH o-quinones are electrophilic and highly reactive with endogenous nucleophiles and yield Lcysteine, N-acetyl-L-cysteine, and GSH conjugates. 12 Electrophilic PAH o-quinones can also form both depurinating DNA adducts in vitro 13 and stable covalent DNA adducts in vitro and in human lung cells. 14−16 Apart from their electrophilicity, PAH o-quinones are also redox active and undergo nonenzymatic or enzymatic reduction to reform catechols at the expense of consuming NADPH. Enzymes that contribute to this redox cycling include NAD(P)(H):quinone oxidoreductase (NQO1), carbonyl reductases (CBR1 and CBR3), and AKRs themselves. Among these three enzymes, the AKRs are the most efficient. 17 ROS produced by redox cycling of the PAH o-quinones mediates DNA damage and can lead to 7,8-dihydro-8-oxo2′deoxyguanosine (8-oxo-dGuo) lesions 18, 19 which contribute to G-to-T transversions in p53. 20, 21 It was found that even nanomolar concentrations of PAH o-quinones were able to generate sufficient ROS to cause a significant increase in 8-oxodGuo. 18, 19 Using B[a]P as a representative PAH and stable isotope dilution liquid chromatography−tandem mass spectrometry, we found that all three pathways of PAH activation were functional in human bronchoalveolar H358 cells. 22 Also, using A549 cells which show high constitutive expression of AKRs, we found that B[a]P-7,8-trans-dihydrodiol (an AKR substrate) was converted to B[a]P-7,8-dione and that the ROS produced increased the level of 8-oxo-dGuo in cellular DNA as measured by stable isotope dilution liquid chromatography−tandem mass spectrometry. 23 Importantly, the level of 8-oxo-dGuo produced from B[a]P-7,8-trans-dihydrodiol was elevated further in the presence of a COMT inhibitor suggesting that a redox cycle was occurring. 23 These observations led to a systematic study of the role of phase II conjugating enzymes in intercepting PAH-catechols to prevent redox cycling. Human catechol-O-methyl transferase (COMT) and sulfotransferases (SULT) 1A1, 1A3, and 1E1 were able to detoxify B 24, 25 Another superfamily of phase II metabolic enzymes, uridine diphosphate glucuronosyltransferases (UGTs), are microsomal enzymes which catalyze the transfer of the glucuronosyl group from uridine 5′-diphospho-glucuronic acid (UDPGA) to substrates that contain alcohols, amines, or carboxylic acids as functional groups. 26 UGTs are divided into two main subfamilies UGT1 and UGT2 based on amino acid sequence identity 27 and are responsible for the glucuronidation of a variety of endogenous compounds and xenobiotics. 28 UGTs are widely distributed in a variety of tissues, including the liver, intestine, brain, and kidney, and the aerodigestive tract, etc.
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UGT1A7, UGT1A8, UGT1A9, and UGT1A10 and UGT2B7 are active against several PAH metabolites, 30−35 while UGT1A10 > UGT1A9 > UGT1A1 > UGT1A7 are the preferred isoforms for catalyzing the glucurondiation of B[a]P-7,8-trans-dihydrodiol. 36 However, the glucuronidation of PAH catechols by UGTs has not been previously examined.
Studies of B[a]P-7,8-dione metabolism and disposition in three human lung cells HBEC-KT, H358, and A549 cells showed rapid disappearance of the quinone accompanied by the formation of phase II conjugates and a N1 or N3-adenine adduct originating from the nucleotide pool. 37 38 All solvents were of HPLC grade, and all other chemicals used were of the highest grade available. UGT1A1, 1A3, and 2B7 Supersomes (microsomes from baculovirus infected insect cells expressing UGTs) were obtained from BD Biosciences (San Jose, CA) and titered before use, using standard substrates.
Cell Lines and Culture Condition. A549 cells (human lung adenocarcinoma cells) were from American Type Culture Collection (ATCC number CCL-185) and cultured in F-12K medium (Kaighn's modification) with supplementation of 10% heat-inactivated FBS, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin. HepG2 cells (hepatoma cells) from ATCC were RT-PCR Analysis of UGT mRNA Expression in Human Cells. Extraction of total RNA from each cell line was conducted using the RNeasy Kit (Qiagen, Valencia, CA). Reverse transcription (RT) was conducted by using GeneAmp RNA PCR Core Kit according to the manufacturer's protocol (Applied Biosystems, Carlsbad, CA). An aliquot of 1 μL of cDNA synthesized in the above RT reaction was used for PCR. The PCR system (25 μL) contained 1× PCR buffer (10 mM Tris-HCl buffer, pH 8.3, and 50 mM KCl), 2.5 mM MgCl 2 , 250 μM dNTPs, 0.2 μM primers, and 0.5 U of Taq DNA polymerase (Applied Biosystems, Carlsbad, CA). The sequences of the forward and reverse primer pairs for the amplification of UGT1A1, 1A3, 1A7, 1A8, 1A9, 1A10, and 2B7 and β-actin transcripts are shown in Table  1. 39−41 PCR amplification was performed with a MyCycler Thermal Cycler PCR system (Bio-Rad, CA) using the following protocol. After an initial denaturation step at 94°C for 3 min, amplification was conducted by denaturation at 95°C for 30 s, annealing at 61°C (for UGT1A1), 63°C (for UGT1A8), or 57°C (for other UGT isoforms) for 30 s, and extension at 72°C for 45 s for 35 cycles. The final extension reaction was performed at 72°C for 7 min. H 2 O was used as the negative control. The control samples were amplified using the same conditions as those described above. An aliquot of 20 μL of PCR products was analyzed by electrophoresis in 2% agarose gel with ethidium bromide and visualized under UV light.
Standard Assay for UGT Activity. UGT enzyme assays were conducted as recommended by BD Biosciences (San Jose, CA). Briefly, the reaction system was composed of 50 mM Tris buffer of pH 7.4, 10 mM MgCl 2 , 1 mM UDPGA, 0.025 mg/mL alamethicin, 50 μM 7-hydroxy-4-(trifluoromethyl)coumarin, and 10 μg of UGT supersome in a final volume of 100 μL. Reactions were initiated by the addition of UDPGA. After incubation at 37°C for 15 min, the reactions were terminated by the addition of 50 μL of 94% acetonitrile/6% glacial acetic acid and were centrifugated at 16,000g for 10 min. An aliquot of 100 μL of supernatant was carefully pipetted, and 50 μL was injected into HPLC/PDA for the quantification of 7-hydroxy-4-(trifluoromethyl)coumarin glucuronide. The reversed-phase column (Agilent Zorbax-ODS C18, 5 μm, 4.6 × 250 mm, CA) was used for the separation of substrate from product. Elution conditions used a flow rate of 1 mL/min with 80%:20% water/methanol (v/v) containing 0.1% formic acid. The methanol concentration was increased from 20% to 80% over 3 min and kept at 80% methanol for 4 min, then changed back to 20% methanol in 1 min followed by a re-equilibration phase of 7 min at 20% methanol.
Kinetic Studies on Glucuronidation of B[a]P-7,8-Catechol. The reactions were performed anaerobically in a glovebox purged with argon. All of the solvent and aqueous solutions were degassed by freeze−pump−thaw cycling five times and stored in sealed containers filled with argon. The experiments were conducted in 1.5 mL amber glass vials with polytetrafluoroethylene/silicone septa closures. The reaction system was composed of 10 mM KPO 4 buffer at pH 7.4, 1.0 mM dithiothreitol, 5.0 mM MgCl 2 , 0.025 mg/ml alamethicin, 1 mM formic acid and were chilled on ice. The reaction mixtures were extracted with 0.5 mL aliquots of ethyl acetate twice by vortex mixing and centrifuged at 16,000g to help phase separation. The combined ethyl acetate layer was backwashed with 0.2 mL of 1% formic acid by vigorous vortexing and centrifuged at 16,000g. The ethyl acetate was then dried by a SpeedVac concentrator (Thermo Scientific). The residue was dissolved in 100 μL of methanol and analyzed by scintillation counting or by HPLC analysis. Kinetic analyses using nonlinear regression were performed by fitting the Michaelis−Menten equation to the data with the program Grafit, ■ RESULTS Gene Expression of UGTs in Human Lung Cells. We performed RT-PCR to identify the UGT isoforms expressed in HepG2 cells and four human lung cells. The UGTs selected were those that have been previously characterized for the glucuronidation of B[a]P-7,8-trans-dihydrdodiol (UGT1A10 > UGT1A9 > UGT1A1 > UGT1A7) 36 and the catechol estrogens (UGT1A8, UGT1A9, and UGT2B7). 42 Although RT-PCR is a semiquantitative approach to analyze gene expression, we found that UGT1A1, 1A3, and 2B7 were expressed at the mRNA level in HepG2 and A549 cells among the seven different UGT isoforms examined (Figure 2) . The current studies focused on the glucuronidation of B[a]P-7,8-catechol by recombinant human UGT1A1, 1A3, and 2B7, which were major UGT isoforms in A549 cells.
Identification of B[a]P-7,8-Catechol Glucuronides Produced by Human Recombinant UGT microsomes.
Supersomes (BD-Biosciences) containing overexpressed human recombinant UGTs were tittered in standard assays. The standard assay for UGT activity using 7-hydroxy-4-(trifluoromethyl)coumarin as a substrate demonstrated that the specific activities of UGT1A1, 1A3, and 2B7 were 1.18 (0.8), 0.96 (0.7), and 1.74 (1.51) nmol of 7-hydroxy-4-(trifluoromethyl)coumarin glucuronide formed/min/mg, respectively, which are comparable to those values previously reported as indicated by the values in parentheses. 43 UGT1A1, 1A3, and 2B7 were all able to catalyze the glucuronidation of B[a]P-7,8-catechol in the presence of UDPGA ( Figure  3A ,B,C), while no conjugates were generated in the absence of UDPGA ( Figure 3D (Figure 7) . Apparent utilization ratios (V maxapp /K m ) showed that UGT1A1 Supersomes were the most catalytically efficient for the glucuronidation of B[a]P-7,8-catechol, followed by UGT1A3 and 2B7 Supersomes ( Table 2 ). The K m values of UGT1A1 and 1A3 were 9.6 and 8.5 μM, respectively, which were slightly lower than that of UGT2B7 at 16.3 μM indicating that the substrate concentration at which half maximal velocity was observed was similar in each case. (Figures 2  and 6D ).
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■ DISCUSSION
We have been conducting a systematic study to elucidate the roles of human enzymes in catalyzing the redox cycling of PAH o-quinones and the roles of phase II enzymes in conjugating PAH catechols that arise from the AKR pathway of PAH activation. Previous studies have shown that AKRs are efficient PAH o-quinone reductases 17 and that the PAH catechols formed can be intercepted by COMTs and SULTs. 24, 25 We now show that UGT1A1, 1A3, and 2B7 are all expressed in A549 cells. Of these, UGT1A3 and 2B7 are the enzymes most likely involved in B It is noteworthy that UGT2B7 is also the dominant isoform involved in the glucuronidation of the structurally related catechol estrogens.
42 UGT2B7 catalyzes the glucuronidation of 4-hydroxycatecholestrogens (hydroxylated estrone/estradiol), which are structurally similar to B[a]P-7,8-catechol. 44 The glucuronidation of 4-hydroxycatecholestrogens shows preference for the C4-hydroxyl group, which would be equivalent to the C7 position of B[a]P-7,8-catechol. Although UGT1A1 was found in the kinetic analysis to have the highest utilization ratio (V max /K m ) and catalyzed the formation of both regioisomeric B[a]P-7,8-catechol glucuronides, no significant M1 was found in A549 cells indicating that it did not contribute to the detoxication of this catechol in these cells.
It is noteworthy that only A549 cells expressed the UGT isoforms studied to any extent. The low expression of UGTs might be anticipated due to the low level of expression previously reported in human lung specimens. Zheng at al. measured the expression of multiple UGTs in 32 human lung tissues by duplex RT-PCR and found that UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10 were not expressed. 29 Similarly, UGT2B4, UGT2B7, UGT2B15, and UGT2B17 were not detected. In later studies, Dillinger et al. showed that UGT1A10 was found in low amounts in human lung specimens. 45 The difference in UGT isoform expression observed in our study versus that observed in the earlier work could reflect differences in measuring UGT expression in human bronchial epithelial cells versus whole lung tissue. Other UGTs that could have been included in our study would be UGT2B10, but up until now, this has only been shown in glucuronidate tobacco specific nitrosamines. 46 The formation of regioisomeric O-monoglucuronides of B[a]P-7,8-catechol also deserves comment. UGT1A1, UGT1A9, and UGT2B7, which are predominately expressed in the liver, were found to form the 7S-monoglucuronide from (±)-B[a]P-7,8-trans-dihydrodiol, whereas the extrahepatic UGT1A7, UGT1A8, and UGT1A10 could form either the 7R-monoglucuronide or the 8S-monoglucuronide, i.e., they produce two different enantiomers. 36 Table 3 . These data reveal that the rates of redox cycling are much greater than the rates of phase II conjugating reactions. Although some uncertainties exist in this comparison due to the differences in expression levels of these enzymes in specific cells, it is unlikely that these will account for the >6,000-fold difference in the specific activities of NQO1 and UGT1A3 to use B[a]P-7,8-dione and B[a]P-7,8-catechol as substrates, respectively. Thus, the ability to intercept the PAH catechols and prevent redox cycling is not an efficient process and could be easily overwhelmed in a cellular environment. This is supported by earlier work in which we showed that B[a]P-7,8-trans-dihydrodiol (AKR substrate) and B[a]P-7,8-dione (AKR product) produced significant ROS and 8-oxo-dGuo formation in A549 cells. 23 Although UGTs were not detected in HBEC-KT, H358, and BEAS-2B under current culture conditions, the contribution of UGTs in human lung cells to B[a]P-7,8-catechol conjugation may be affected by the induction of UGTs. Cigarette smoke increases UGT activity. 47, 48 It has been proposed that the expression level of UGT1A4 in the human small airway epithelium was elevated as a result of nuclear factor erythroid 2 p45-related factors (Nrf2) activation. However, UGT1A4 does not appear to be responsible for B[a]P-7,8-catechol glucuronidation in our experiments to date. 49 It has also been demonstrated that UGT1A10 and UGT1A8 are coordinately regulated by the aryl hydrocarbon receptor (AhR) and Nrf2 and that the Nrf2 response requires the presence of AhR. 50 Both PAHs and PAH o-quinones such as B[a]P-7,8-dione are the ligands of the AhR, which is required for the induction of UGTs by Nrf2. 51−53 With the induction of UGTs, the detoxification of B[a]P-7,8-dione by UGTs in smokers could become more significant.
The AKR1C genes involved in the formation and redox cycling of PAH o-quinones are also highly induced by the Nrf2-Keap 1 system. 54, 55 Inducers that activate Nrf2 include electrophiles and ROS and not surprisingly PAH o-quinones. Thus, the induction of AKR1C genes with the products of PAH-trans-dihydrodiol oxidation, namely, PAH o-quinones, could lead to an exacerbation of ROS formation which may not be easily countered by UGT induction. 
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